Dual inhibition of complement component 5 and leukotriene B4 by topical rVA576 in atopic keratoconjunctivis: TRACKER phase 1 clinical trial results

por Sánchez-Tabernero, Sara, Fajardo-Sanchez, Julia, Weston-Davies, Wynne, Parekh, Mohit, Kriman, Jaime, Kaye, Stephen, Ahmad, Sajjad
Publicado 2021